THE CD70 ANTIBODY CUSATUZUMAB SHOWS PROMISE IN ACUTE MYELOID LEUKEMIA

被引：1
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2020年 / 10卷 / 09期
关键词：
D O I：
10.1158/2159-8290.cd-rw2020-106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1251 / 1251
页数：1
相关论文
共 50 条
  • [1] Targeting CD70 with Cusatuzumab Eliminates Acute Myeloid Leukemia Stem Cells in Humans
    Ochsenbein, Adrian F.
    Pabst, Thomas
    Hopner, Sabine
    Bacher, Vera Ulrike
    Hinterbrandner, Magdalena
    Banz, Yara
    Mueller, Rouven
    Manz, Markus G.
    Gharib, Walid
    Francisco, David
    Bruggmann, Remy
    Van Rompaey, Luc
    Moshir, Mahan
    Delahaye, Tim
    Gandini, Domenica
    Erzeel, Ellen
    Hultberg, Anna
    Fung, Samson
    De Haard, Hans
    Leupin, Nicolas
    Riether, Carsten
    BLOOD, 2019, 134
  • [2] Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
    Riether, Carsten
    Pabst, Thomas
    Hoepner, Sabine
    Bacher, Ulrike
    Hinterbrandner, Magdalena
    Banz, Yara
    Mueller, Rouven
    Manz, Markus G.
    Gharib, Walid H.
    Francisco, David
    Bruggmann, Remy
    van Rompaey, Luc
    Moshir, Mahan
    Delahaye, Tim
    Gandini, Domenica
    Erzeel, Ellen
    Hultberg, Anna
    Fung, Samson
    de Haard, Hans
    Leupin, Nicolas
    Ochsenbein, Adrian F.
    NATURE MEDICINE, 2020, 26 (09) : 1459 - 1467
  • [3] Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
    Carsten Riether
    Thomas Pabst
    Sabine Höpner
    Ulrike Bacher
    Magdalena Hinterbrandner
    Yara Banz
    Rouven Müller
    Markus G. Manz
    Walid H. Gharib
    David Francisco
    Remy Bruggmann
    Luc van Rompaey
    Mahan Moshir
    Tim Delahaye
    Domenica Gandini
    Ellen Erzeel
    Anna Hultberg
    Samson Fung
    Hans de Haard
    Nicolas Leupin
    Adrian F. Ochsenbein
    Nature Medicine, 2020, 26 : 1459 - 1467
  • [4] Targeting CD70 in acute myeloid leukaemia
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2020, 19 (8) : 512 - 512
  • [5] Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents
    Marques-Piubelli, Mario L.
    Kumar, Bijender
    Basar, Rafet
    Panowski, Siler
    Srinivasan, Surabhi
    Norwood, Kevin
    Prashad, Sacha
    Szenes, Victoria
    Balakumaran, Arun
    Arandhya, Akanksha
    Lu, Wei
    Khan, Khaja
    Duenas, Daniela
    McAllen, Salome
    Gomez, Javier A.
    Burks, Jared K.
    Acharyal, Sunil
    Borthakur, Gautam
    Wang, Wei-Lien
    Wang, Wei
    Wang, Sa
    Solis, Luisa M.
    Marin, David
    Rezvani, Katayoun
    Daher, May
    Vega, Francisco
    VIRCHOWS ARCHIV, 2024, 485 (05) : 937 - 941
  • [6] CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia
    Riether, Carsten
    Schurch, Christian M.
    Buhrer, Elias D.
    Hinterbrandner, Magdalena
    Huguenin, Anne-Laure
    Hoepner, Sabine
    Zlobec, Inti
    Pabst, Thomas
    Radpour, Ramin
    Ochsenbein, Adrian F.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (02): : 359 - 380
  • [7] Use of CD70 Targeted Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Acute Myeloid Leukemia (AML)
    Leick, Mark
    Scarfo, Irene
    Choi, Bryan D.
    Larson, Rebecca
    Bouffard, Amanda A.
    Castano, Ana
    Cabral, Maria L.
    Schmidts, Andrea
    Frigault, Matthew J.
    Maus, Marcela V.
    BLOOD, 2019, 134
  • [8] CD70 Expression in Naive Treated and Relapsed Acute Myeloid Leukemia Patients: A Potential Therapeutic Target in Relapsed Settings
    Marques-Piubelli, Mario L.
    Panowski, Siler
    Srinivasan, Surabhi
    Norwood, Kevin
    Prashad, Sacha
    Szenes, Victoria
    Balakumaran, Arun
    Arandhya, Akanksha
    Lu, Wei
    Khan, Khaja
    Borthakur, Gautam
    Wang, Wei-Lien
    Wang, Wei
    Soto, Luisa Solis
    Vega, Francisco
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1191 - S1192
  • [9] Targeting CD70 in acute myeloid leukaemia: an emerging therapeutic angle in combinatorial treatment
    Fathi, Amir T.
    LANCET HAEMATOLOGY, 2023, 10 (11): : E868 - E870
  • [10] CD70 targeting bi-specific Natural Killer cell Engager (BIKE) eliminate acute myeloid leukemia cells
    Boy, M.
    Bratschi, H.
    Riether, C.
    Ochsenbein, A.
    SWISS MEDICAL WEEKLY, 2023, 153 : 5S - 6S
12345